Hummingbird Bioscience hummingbirdbioscience.com


Hummingbird Bioscience is a biotherapeutics company focused on the discovery and development of precision antibody therapeutics for difficult-to-treat conditions. Leveraging its proprietary rational antibody discovery platform and deep experience in systems biology, Hummingbird Bioscience is able to accurately identify important disease targets and engineer antibodies to precisely hit these difficult targets. Hummingbird Bioscience has developed a pipeline of highly promising novel therapies.

Hummingbird Bioscience is a biotherapeutics company focused on the discovery and development of precision antibody therapeutics for difficult-to-treat conditions. Leveraging its proprietary rational antibody discovery platform and deep experience in ...Show all

Company (Alive / Active)

Phone:

Fax:

Temasek Lifescience Laboratories
1 Research Link
117604
Singapore

Latest News

See more competitors data Competitors
Total Funding Date of Last Funding
Hummingbird Bioscience $38.1M May 11, 2020

Web Traffic

Rank

Show (-10)

Engagement (PVPU)

Show (+1%)

Domain Authority Score
Show
Page Views Per Million (PVPM)
Show
Reach Per Million
Show

SEO Statistics

Domain Authority Score Show
Page Authority Score Show
No. External Links Show
No. Links Show

Web Traffic Statistics - Growth

Per Week Per Month Per 6 Months Per Year
Rank Login to see details
Page Views Per Million Login to see details
Page Views Per User Login to see details
Reach Per Million Login to see details

Related Hummingbird Bioscience Jobs

jobs by Indeed job
						search

Investors

Investor Investor Type Location Participating Rounds
See all 14 investors

Board Members

There is no Competitors data available for this company. Please select another tab.

Patents

Title Application Date Patent Date Status
(Patent / Application)
Her3 antigen-binding molecules Oct 08, 2019 May 26, 2020 Patent
Vista antigen-binding molecules Oct 08, 2019 Apr 28, 2020 Patent
Vista antigen-binding molecules Mar 18, 2020 Application
Her3 antigen-binding molecules Feb 28, 2020 Application
Vista antigen-binding molecules Nov 05, 2018 Application
See all 6 patents